VideoCannabisPodcastsTrade To Black

Organigram And Curaleaf Leadership Talk Latest Earnings

By Shadd Dales On May 13, 2025

Shadd Dales and Anthony Varrell sit down with two of the biggest names in the cannabis industry: Beena Goldenberg, CEO of Organigram (NASDAQ: OGI), and Boris Jordan, Executive Chairman of Curaleaf (OTCQX: CURLF). Beena breaks down what’s behind Organigram’s record-setting quarter of revenue hitting $65.6 million, fueled by the Motif Labs acquisition and strong growth overseas. Boris Jordan unpacks Curaleaf’s Q1 performance — $310 million in revenue and improved margins — and gives us a real look at how the company is navigating market headwinds. Find out why Boris pulls no punches on Curaleaf’s path forward, slamming New York’s licensing model as “un-American.”

First up on the podcast is Organigram CEO Beena Goldenberg, who shares the highlights of their most recent report. Organigram had a breakout quarter with $65.6M in net revenue, $102M in gross sales, and a major EBITDA turnaround. Motif’s acquisition is driving both organic growth and synergies—including $15M in cost savings. She also outlines the shift to centralized distribution in London, ON, and a strategic emphasis on beverages are part of the recipe for success.

Tune in to the full interview to hear more about Organigram’s push into the hemp-derived beverage market and what’s next for their partnership with BAT, plus international expansion in the EU and Australia.

Curaleaf Executive Chairman Boris Jordan brings unfiltered insights in their latest report. Despite Q1 revenue pressure, Curaleaf reported $310M and a 50% adjusted gross margin. Jordan highlights Curaleaf’s pivot to premium flower, product consolidation, and new extract technologies like “ACE,” which he claims offers the cleanest vape oil on the market. Internationally, Curaleaf’s EUGMP vape certification opens massive doors in Europe and Australia. In Florida, Boris teases a split-store strategy (regulated cannabis on one side, hemp on the other) and calls out New York’s licensing fees as unconstitutional and politically motivated.

Both Organigram’s and Curaleaf’s guests agree: hemp is rewriting cannabis access—especially in markets where THC access is limited. This and more in this episode of Trade To Black.

AN – Sidebar Square

Shadd Dales

Shadd Dales is the Founder and President of The Dales Report and has an extensive background in the business media industry.

His work translates into over 15 years in mainstream media that included roles with BNN Bloomberg, CTV Properties and the iHeart Radio Network.

Shadd is considered one of the leading on air talents in both the cannabis and psychedelic space and has interviewed some of the most notable CEO names in the industry.

Shadd’s vision is to establish a content platform that is equivalent to a mainstream broadcast produced in a format that is relevant for today’s investor.